Nwk Group, Inc. Novo Cure LTD Transaction History

Nwk Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$124.11 - $190.17 $63,296 - $96,986	-510 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$112.16 - $174.14 $4,486 - $6,965	-40 Reduced 7.27%	510 $88,000
Q2 2020 Aug 13, 2020	BUY	$57.2 - $74.41 $2,860 - $3,720	50 Added 10.0%	550 $33,000
Q1 2020 May 12, 2020	SELL	$57.05 - $95.75 $28,525 - $47,875	-500 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$68.3 - $93.8 $34,150 - $46,900	500 New	500 $42,000

278

73.2M

1.43M

832K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.68B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Nwk Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Nwk Group, Inc. with notifications on news.